NCT00265135 2014-07-03
A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma
Centocor, Inc.
Phase 1/2 Completed
Clinical Trials
3 trialsNCT00401765 2014-05-26
A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer
Centocor, Inc.
Phase 1 Completed
NCT00433446 2013-02-05
S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
SWOG Cancer Research Network
Phase 2 Completed